期刊文献+

促炎细胞因子在交感/儿茶酚胺介导心脏重塑中的作用 被引量:6

Roles of proinflammatory cytokines in cardiac remodeling induced by sympathetic nervous system / catecholamine
下载PDF
导出
摘要 高血压和心力衰竭等心血管疾病是低度非感染性炎症反应性疾病,其病理过程是在非外源性感染因素造成的组织损伤作用下,外周血白细胞(包括淋巴细胞、单核-巨噬细胞、中性粒细胞等)向靶器官浸润,自身或促进靶器官合成和分泌细胞因子,后者通过自分泌或旁分泌的途径发挥生物学功能。 Sympathetic nervous system is excessively activated under strong stress, which leads to a significant rise of plasma catecholamine concentration, then activates the β-adrenoceptors (β-ARs) in the heart and mediates the development of cardiac remodeling and heart failure. Meanwhile, chronic β-ARs activation has been proved to be involved in cardiac sterile inflammation by mediating the synthesis and secretion of cytokines, which subsequently mediates cardiac fibrosis and dysfunction. This review summarizes a number of important proinflammatory cytokines involved in the process of cardiac pathological remodeling under chronic adrenergic stimulation and the application of neutralizing antibodies on specifically targeting cytokines in the treatment of cardiovascular diseases.
作者 李昊 张幼怡
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2014年第6期1001-1004,共4页 Journal of Peking University:Health Sciences
关键词 细胞因子类 受体 肾上腺素能Β 心力衰竭 心室重构 Cytokines Receptors, adrenergic, beta Heart failure Ventricular remodeling
  • 相关文献

参考文献26

  • 1Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor al- pha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death [ J ]. J Clin Invest, 1996, 98(12) : 2854 -2865.
  • 2Melendez GC, McLarty JL, Levick SP, et al. Interleukin 6 medi- ates myocardial fibrosis, concentric hypertrophy, and diastolic dys- function in rats [J]. Hypertension, 2010, 56(2) : 225 -231.
  • 3Brown RD, Jones GM, Laird RE, et al. Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts [ J ]. Bio- chem Biophys Res Commun, 2007, 362( 1 ) : 200- 205.
  • 4Feldman DS, Elton TS, Sun B, et al. Mechanisms of disease: detrimental adrenergie signaling in acute decompensated heart fail- ure [J]. Nat Clin Pract Cardiovasc Med, 2008, 5 (4): 208 - 218.
  • 5Murray DR, Prabhu SD, Chandrasekar B. Chronic beta-adrener- gic stimulation induces myocardial proinflammatory cytokine ex- pression [J]. Circulation, 2000, 101 (20): 2338-2341.
  • 6Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure [J]. J Am Coil Cardiol, 1998, 31 (2) : 391 -398.
  • 7Yin F, Li P, Zheng M, et al. Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart [J]. J Bid Chem, 2003, 278(23) : 21070 -21075.
  • 8Chen C, Du J, Feng W, et al. beta-Adrenergie receptors stimu- late interleukin-6 production through Epac-dependent activation of PKCdelta/p38 MAPK signalling in neonatal mouse cardiac fibro- blasts [J]. Br J Pharmaeol, 2012, 166(2): 676-688.
  • 9Xu Q, Dalie A, Fang L, et al. Myocardial oxidative stress con- tributes to transgenie beta-adrenoeeptor activation-induced eardio- myopathy and heart failure [J]. BrJ Pharmaeol, 2011, 162(5) : 1012 - 1028.
  • 10Prabhu SD, Chandrasekar B, Murray DR, et al. beta-adrenergie blockade in developing heart failure: effects on myocardial inflam- matory eytokines, nitric oxide, and remodeling [ J ]. Circulation, 2000, 101(17) : 2103 -2109.

同被引文献54

  • 1李敏,王硕仁,赵明镜,吕浠滢.活血益气方药对心肌梗死后心力衰竭大鼠心肌细胞凋亡的影响[J].中西医结合心脑血管病杂志,2005,3(1):33-35. 被引量:20
  • 2Papanikolaou J, Tsolaki V, Makris D, et al. Early levosimendan administration may improve outcome in patients with subarach- noid hemorrhage complicated by acute heart failure [J]. Int J Cardiol, 2014, 176(3).-1435-1437.
  • 3Cullen L,Than M,Peacock WF. Undetectable hs-cTnT in the e- mergency department and risk of myocardial infarction [J]. J Am Coll Cardiol, 2014, 64(6) ;632-633.
  • 4Chon H,Lee S,Yoon SY,et al. SERS-based competitive immu- noassay of troponin I and CK-MB markers for early diagnosis of acutemyocardial infaretion[-J;. Chem Commun (Camb), 2014, 50(9) : 1058-1060.
  • 5Rossignol P, Zannad F, Pitt B. Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition inheart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries[J]. Int J Cardi- ol, 2014, 177(3);731-733.
  • 6Rengo G, Pagano G, Parisi V, et al. Changes of plasma norepi- nephrine and serum N-terminal pro-brain natriuretic peptide af- ter exereise training predict survival in patients with heart fail- ure[J]. Int J Cardiol, 2014,171 (3) : 384-389.
  • 7Onur S,Niklowitz P,Jacobs G,et al. Association between serum level of ubiquinol and NT-proBNP, a marker for chronic heart failure, in healthy elderly subjects [J]. Biofactors, ;015, 41 (1) ;35 43.
  • 8Koller L, Blum S, Korpak M, et al. Predictive power of the frac- talkine receptor CX3CR1 on CD4 T cells in patients with chron- ic heart failure [J]. Int J Cardiol, 2014, 171(1) ;96 97.
  • 9Varsano N, Fargion I, Wolf SG, et al. Formation of 3D Cho- lesterol Crystals from 2D nucleation sites in lipid bilayer mem- branes., implications for atherosclerosisEJJ. J Am Chem Soc, 2015, 137(4) :1601-1607.
  • 10Liu YT, Peng JB, Jia HM, et al. UPLC-Q/TOF MS standard- ized Chinese formula Xin-Ke-Shu for the treatment of athero- sclerosis in a rabbit model;-J3. Phytomedicine, 2014, 21 (11) 1364-1372.

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部